vs
Side-by-side financial comparison of Commercial Vehicle Group, Inc. (CVGI) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
Commercial Vehicle Group, Inc. is the larger business by last-quarter revenue ($154.8M vs $85.1M, roughly 1.8× 4D Molecular Therapeutics, Inc.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -5.2%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $8.7M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -10.8%).
WABCO Holdings, Inc. was a U.S.-based provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. In 2007, the Vehicle Control Systems was spun off as WABCO Holdings Inc., an American provider of electronic braking, stability, suspension and transmission automation systems for heavy-duty commercial vehicles. Their products are present in many commercial vehicles such as trucks, buses, trailers and off-highway vehicles but they ...
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CVGI vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $154.8M | $85.1M |
| Net Profit | — | $19.4M |
| Gross Margin | 9.7% | — |
| Operating Margin | -1.2% | 17.3% |
| Net Margin | — | 22.8% |
| Revenue YoY | -5.2% | 8508900.0% |
| Net Profit YoY | — | 139.1% |
| EPS (diluted) | — | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.8M | $85.1M | ||
| Q3 25 | $152.5M | $90.0K | ||
| Q2 25 | $172.0M | $15.0K | ||
| Q1 25 | $169.8M | $14.0K | ||
| Q4 24 | $163.3M | $1.0K | ||
| Q3 24 | $171.8M | $3.0K | ||
| Q2 24 | $193.7M | $5.0K | ||
| Q1 24 | $194.6M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $-7.1M | $-56.9M | ||
| Q2 25 | $-4.8M | $-54.7M | ||
| Q1 25 | $-4.3M | $-48.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.5M | $-43.8M | ||
| Q2 24 | $-1.6M | $-35.0M | ||
| Q1 24 | $2.9M | $-32.4M |
| Q4 25 | 9.7% | — | ||
| Q3 25 | 10.5% | — | ||
| Q2 25 | 11.4% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 11.9% | — |
| Q4 25 | -1.2% | 17.3% | ||
| Q3 25 | -0.7% | -67983.3% | ||
| Q2 25 | 0.5% | -396373.3% | ||
| Q1 25 | 0.8% | -383007.1% | ||
| Q4 24 | -3.2% | — | ||
| Q3 24 | -0.6% | -1704400.0% | ||
| Q2 24 | 0.5% | -849120.0% | ||
| Q1 24 | 2.3% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | -4.6% | -63195.6% | ||
| Q2 25 | -2.8% | -364386.7% | ||
| Q1 25 | -2.5% | -342657.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.5% | -1461433.3% | ||
| Q2 24 | -0.8% | -699060.0% | ||
| Q1 24 | 1.5% | -115717.9% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $-1.01 | ||
| Q2 25 | — | $-0.98 | ||
| Q1 25 | — | $-0.86 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.79 | ||
| Q2 24 | $-0.05 | $-0.63 | ||
| Q1 24 | $0.09 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | $104.9M | — |
| Stockholders' EquityBook value | $133.4M | $505.7M |
| Total Assets | $391.7M | $566.7M |
| Debt / EquityLower = less leverage | 0.79× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M | ||
| Q1 24 | — | $525.9M |
| Q4 25 | $104.9M | — | ||
| Q3 25 | $108.2M | — | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $117.4M | — | ||
| Q4 24 | $135.5M | — | ||
| Q3 24 | $128.8M | — | ||
| Q2 24 | $142.0M | — | ||
| Q1 24 | $155.7M | — |
| Q4 25 | $133.4M | $505.7M | ||
| Q3 25 | $136.5M | $369.0M | ||
| Q2 25 | $142.6M | $420.9M | ||
| Q1 25 | $136.7M | $469.7M | ||
| Q4 24 | $135.6M | $510.6M | ||
| Q3 24 | $179.3M | $552.9M | ||
| Q2 24 | $169.6M | $588.3M | ||
| Q1 24 | $175.5M | $600.6M |
| Q4 25 | $391.7M | $566.7M | ||
| Q3 25 | $400.3M | $424.0M | ||
| Q2 25 | $429.8M | $473.6M | ||
| Q1 25 | $419.8M | $515.7M | ||
| Q4 24 | $424.6M | $560.4M | ||
| Q3 24 | $495.3M | $604.0M | ||
| Q2 24 | $503.2M | $620.1M | ||
| Q1 24 | $509.2M | $629.9M |
| Q4 25 | 0.79× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.00× | — | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.89× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $28.6M |
| Free Cash FlowOCF − Capex | $8.7M | $28.5M |
| FCF MarginFCF / Revenue | 5.6% | 33.5% |
| Capex IntensityCapex / Revenue | 2.3% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $34.0M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $28.6M | ||
| Q3 25 | $-1.7M | $-46.5M | ||
| Q2 25 | $18.9M | $-43.4M | ||
| Q1 25 | $15.2M | $-47.8M | ||
| Q4 24 | $-26.6M | $-134.6M | ||
| Q3 24 | $-17.1M | $-29.4M | ||
| Q2 24 | $12.6M | $-30.2M | ||
| Q1 24 | $-2.4M | $-29.1M |
| Q4 25 | $8.7M | $28.5M | ||
| Q3 25 | $-3.5M | $-46.6M | ||
| Q2 25 | $17.4M | $-43.4M | ||
| Q1 25 | $11.4M | $-48.4M | ||
| Q4 24 | $-30.6M | $-138.4M | ||
| Q3 24 | $-20.3M | $-31.2M | ||
| Q2 24 | $6.4M | $-30.6M | ||
| Q1 24 | $-7.4M | $-29.8M |
| Q4 25 | 5.6% | 33.5% | ||
| Q3 25 | -2.3% | -51765.6% | ||
| Q2 25 | 10.1% | -289620.0% | ||
| Q1 25 | 6.7% | -345635.7% | ||
| Q4 24 | -18.7% | -13837100.0% | ||
| Q3 24 | -11.8% | -1038966.7% | ||
| Q2 24 | 3.3% | -611840.0% | ||
| Q1 24 | -3.8% | -106421.4% |
| Q4 25 | 2.3% | 0.1% | ||
| Q3 25 | 1.2% | 101.1% | ||
| Q2 25 | 0.9% | 440.0% | ||
| Q1 25 | 2.2% | 4507.1% | ||
| Q4 24 | 2.4% | 378600.0% | ||
| Q3 24 | 1.9% | 59266.7% | ||
| Q2 24 | 3.2% | 6980.0% | ||
| Q1 24 | 2.6% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.79× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.80× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
FDMT
Segment breakdown not available.
